NASDAQ · NVAX
Novavax, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for NVAX: Nov 5, 2026
Novavax, Inc. Common Stock is estimated to report earnings on 11/05/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 3 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.33. The reported EPS for the same quarter last year was $-0.62.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.33 | $-0.25 | $-0.42 | 3 |
| Dec 2026 | $0.17 | $0.49 | $-0.15 | 2 |
| Mar 2027 | $-0.27 | $-0.27 | $-0.27 | 1 |
| Jun 2027 | $0.13 | $0.13 | $0.13 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Zacks · BNK Invest- RTTNews · Oct 29, 12:26 PM EDTNovavax Gains $125 Mln Payment As Sanofi Begins Phase 3 Combination Vaccine Trial; Stock Up(RTTNews) – Novavax, Inc. (NVAX) said it has earned a $125 million milestone payment following the initiation of Sanofi's Phase 3 influenza-COVID-19 combination vaccine trial in Europe, which is evaluating its COVID-19 vaccine Nuvaxovid.
- Zacks · Oct 29, 9:00 AM EDTNovavax (NVAX) May Report Negative Earnings: Know the Trend Ahead of Q3 ReleaseNovavax (NVAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks · Oct 26, 4:45 PM EDTNovavax (NVAX) Stock Falls Amid Market Uptick: What Investors Need to KnowNovavax (NVAX) concluded the recent trading session at $9.4, signifying a -3.09% move from its prior day's close.
- Zacks · Oct 23, 6:19 AM EDTBiogen (BIIB) Surges 5.3%: Is This an Indication of Further Gains?Biogen (BIIB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
- Zacks · Oct 21, 8:00 AM EDTInvestors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to KnowNovavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
- Zacks · Oct 19, 4:45 PM EDTNovavax (NVAX) Stock Declines While Market Improves: Some Information for InvestorsNovavax (NVAX) concluded the recent trading session at $10.82, signifying a -3.91% move from its prior day's close.
- Zacks · Oct 13, 4:45 PM EDTNovavax (NVAX) Increases Despite Market Slip: Here's What You Need to KnowIn the most recent trading session, Novavax (NVAX) closed at $12.82, indicating a +1.26% shift from the previous trading day.
- Zacks · Oct 12, 10:12 AM EDTVaccine Stocks Rally on Reports of U.S.-led Push for Cancer VaccinesMRNA, BNTX and NVAX shares rally after reports of a planned NIH-backed initiative to accelerate personalized cancer vaccines and expand research funding.
- Zacks · Oct 9, 8:00 AM EDTNovavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should KnowNovavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
- Zacks · Oct 6, 4:45 PM EDTNovavax (NVAX) Stock Sinks As Market Gains: Here's WhyIn the latest trading session, Novavax (NVAX) closed at $11.27, marking a -10.31% move from the previous day.
- BNK Invest · Oct 6, 3:21 PM EDTNotable Tuesday Option Activity: AWR, NVAX, INTCLooking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in American States Water Co (Symbol: AWR), where a total volume of 1,731 contracts has been traded thus far today, a contract volume which is representative of appr
- Zacks · Oct 6, 2:13 AM EDTNovavax (NVAX) Surges 20.1%: Is This an Indication of Further Gains?Novavax (NVAX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Novavax, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.